Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.763 | 0.360 | 17 | 35880776 | 5 prime UTR variant | C/T | snv | 0.27 |
|
Infections | 0.020 | 1.000 | 2 | 2011 | 2013 | |||||||
|
0.925 | 0.040 | 17 | 35880401 | 5 prime UTR variant | G/C | snv | 2.0E-02 |
|
Infections | 0.020 | 1.000 | 2 | 2011 | 2013 | |||||||
|
0.763 | 0.360 | 17 | 35880776 | 5 prime UTR variant | C/T | snv | 0.27 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.763 | 0.360 | 17 | 35880776 | 5 prime UTR variant | C/T | snv | 0.27 |
|
Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2006 | 2006 | |||||||
|
0.763 | 0.360 | 17 | 35880776 | 5 prime UTR variant | C/T | snv | 0.27 |
|
Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.763 | 0.360 | 17 | 35880776 | 5 prime UTR variant | C/T | snv | 0.27 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.763 | 0.360 | 17 | 35880776 | 5 prime UTR variant | C/T | snv | 0.27 |
|
Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.763 | 0.360 | 17 | 35880776 | 5 prime UTR variant | C/T | snv | 0.27 |
|
Infections | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.763 | 0.360 | 17 | 35880776 | 5 prime UTR variant | C/T | snv | 0.27 |
|
Neoplasms; Endocrine System Diseases | 0.010 | < 0.001 | 1 | 2013 | 2013 | |||||||
|
0.763 | 0.360 | 17 | 35880776 | 5 prime UTR variant | C/T | snv | 0.27 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.763 | 0.360 | 17 | 35880776 | 5 prime UTR variant | C/T | snv | 0.27 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.763 | 0.360 | 17 | 35880776 | 5 prime UTR variant | C/T | snv | 0.27 |
|
Nervous System Diseases; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.925 | 0.040 | 17 | 35880401 | 5 prime UTR variant | G/C | snv | 2.0E-02 |
|
Infections | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.925 | 0.080 | 17 | 35879999 | intron variant | A/G | snv | 0.16 |
|
Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.925 | 0.080 | 17 | 35879999 | intron variant | A/G | snv | 0.16 |
|
Infections; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.925 | 0.080 | 17 | 35879999 | intron variant | A/G | snv | 0.16 |
|
Infections | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
1.000 | 0.080 | 17 | 35872637 | intron variant | A/T | snv | 0.27 |
|
Digestive System Diseases; Infections | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
1.000 | 0.080 | 17 | 35872158 | 3 prime UTR variant | A/C;G | snv |
|
Digestive System Diseases; Infections | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.851 | 0.120 | 17 | 35878529 | missense variant | C/T | snv | 1.6E-05 | 7.0E-06 |
|
0.010 | 1.000 | 1 | 2006 | 2006 | |||||||
|
0.851 | 0.120 | 17 | 35878529 | missense variant | C/T | snv | 1.6E-05 | 7.0E-06 |
|
Nervous System Diseases | 0.010 | 1.000 | 1 | 2004 | 2004 | ||||||
|
0.851 | 0.120 | 17 | 35878529 | missense variant | C/T | snv | 1.6E-05 | 7.0E-06 |
|
Nervous System Diseases; Mental Disorders | 0.010 | 1.000 | 1 | 2004 | 2004 | ||||||
|
0.851 | 0.120 | 17 | 35878529 | missense variant | C/T | snv | 1.6E-05 | 7.0E-06 |
|
Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2006 | 2006 |